CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 9,375 shares (grant or award)
- 4 Grant or award Director acquired 14,285 shares (grant or award)
- 4 Grant or award Director acquired 30,357 shares (grant or award)
- 4 Grant or award Director acquired 21,428 shares (grant or award)
- 4 Grant or award Director acquired 19,196 shares (grant or award)
- 4 Open-market buy Chief Business Officer bought 20,000 shares at $2.46 ($49,200)
- 4 Open-market buy 10% owner bought 1,470,588 shares at $3.40 ($4,999,999)
- 3 Insider Initial Statement of Ownership
Page 3 of 9 · 176 filings